Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
34.54
-2.75 (-7.37%)
At close: Sep 23, 2026, 4:00 PM EDT
34.54
0.00 (0.00%)
After-hours: Sep 23, 2026, 4:10 PM EDT
Immunovant Employees
Immunovant had 315 employees as of March 31, 2026. The number of employees decreased by 47 or -12.98% compared to the previous year.
Employees
315
Change (1Y)
-47
Growth (1Y)
-12.98%
Revenue / Employee
n/a
Profits / Employee
-$1,708,625
Market Cap
7.13B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 315 | -47 | -12.98% |
| Mar 31, 2025 | 362 | 155 | 74.88% |
| Mar 31, 2024 | 207 | 43 | 26.22% |
| Mar 31, 2023 | 164 | 40 | 32.26% |
| Mar 31, 2022 | 124 | 56 | 82.35% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Ionis Pharmaceuticals | 1,480 |
| ImmunityBio | 691 |
| Vaxcyte | 507 |
| Rhythm Pharmaceuticals | 414 |
| TG Therapeutics | 399 |
| Praxis Precision Medicines | 168 |
| CG Oncology | 142 |
IMVT News
- 3 hours ago - Wainwright maintains confidence in Immunovant’s pipeline despite CLE setback - TheFly
- 9 hours ago - Immunovant announces IMVT-1402 study did not achieve statistical significance - TheFly
- 9 hours ago - Immunovant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus - GlobeNewsWire
- 6 weeks ago - Immunovant price target raised to $45 from $43 at BofA - TheFly
- 6 weeks ago - Immunovant Slides: Corporate presentation - Filings
- 6 weeks ago - Immunovant reports Q2 EPS (75c), consensus (61c) - TheFly
- 6 weeks ago - Immunovant Earnings Call Transcript: Q1 2027 - Transcripts
- 6 weeks ago - Immunovant Earnings release: Q1 2027 - Filings